Robert W. Pangia, Director at BIOGEN IDEC INC. (BIIB), sold 3,625 shares at $410.06 ($1.5M) on 2015-03-10, disclosed to the SEC on 2015-03-11.
Scheduled sale ($1.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $410.06 | 400 | $164K | 10.9% |
| 2 | $410.61 | 200 | $82K | 5.5% |
| 3 | $411.33 | 100 | $41K | 2.7% |
| 4 | $411.46 | 300 | $123K | 8.2% |
| 5 | $412.97 | 700 | $289K | 19.3% |
| 6 | $413.99 | 1,000 |
| $414K |
| 27.6% |
| 7 | $415.14 | 300 | $125K | 8.3% |
| 8 | $416.25 | 525 | $219K | 14.6% |
| 9 | $417.27 | 100 | $42K | 2.8% |
| Total | $413.40 avg | 3,625 | $1.5M | 100% |
| Filing → |
| BIIB | SELL | 2017-01-10 | $3.2M | — | Filing → |
| BIIB | SELL | 2014-04-02 | $1.9M | — | Filing → |
| BIIB | SELL | 2014-01-07 | $1.7M | — | Filing → |